Hannah Gordon, PhD
Chief Scientific Officer
Enveda
Hannah Gordon is Chief Scientific Officer at Enveda. She brings extensive expertise in translational biology and strategic drug discovery. With over a decade in biotech, including at Recursion, Hannah has become a leader in leveraging cutting-edge technologies for drug discovery. She excels at transforming complex scientific concepts into actionable processes, fostering cross-functional collaboration, and driving progress in translating nature into medicine. Her blend of molecular biology expertise and commercial acumen makes her a key innovator, continually pushing boundaries in drug discovery and development. She holds a Ph.D. in Human Genetics, and an HHMI-sponsored MS in Clinical Investigation from the University of Utah.
Sessions



